Results 181 to 190 of about 206,766 (202)

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Denis Y Logunov, Inna V Dolzhikova, Amir I Tukhvatulin   +2 more
exaly  

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Vaccine, 2021
Mariano Young, Daniel A Scott, Yahong Peng   +2 more
exaly  

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

Vaccine, 2011
Julianne Gee, Allison L Naleway, Irène Shui   +2 more
exaly  

Current controversies in the USA regarding vaccine safety

Expert Review of Vaccines, 2010
Archana Chatterjee
exaly  

Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine

Vaccine, 2015
Suzanne M Garland, Tak-Hong Cheung, Lone Kjeld Petersen   +2 more
exaly  

Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety – executive summary

Vaccine, 2017
Priya Bahri, Frank Destefano, Bhagwat Gunale   +2 more
exaly  

Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04

Vaccine, 2004
J N Zuckerman, B Genton, J van Hattum
exaly  

Safety of pertussis vaccine

The Lancet, 1990
openaire   +2 more sources

Human therapeutic cocaine vaccine: safety and immunogenicity

Vaccine, 2002
Thomas R Kosten, Marc Rosen
exaly  

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2013
Fan-Yue Meng, Jing-Xin Li, Kai Chu
exaly